Press Release
April 7, 2026
Kaiseraugst, Switzerland. April, 7 2026
The beauty industry is evolving rapidly, shaped by consumers who expect more than product performance alone. They seek solutions that reflect their lifestyles, support long-term skin and hair health, and deliver both efficacy and emotional value. This shift is redefining how brands innovate and where science must lead.
At in-cosmetics Global in Paris, dsm-firmenich presents how its Dream-led Science anticipates this consumer transformation. “Our solutions reflect a deep understanding of evolving consumer needs and expectations,” said Parand Salmassinia, President of Beauty & Care at dsm-firmenich. “By combining future-forward thinking with our scientific expertise, we dare to dream big and push the boundaries of science, supporting our customers’ brands with innovative, pioneering, and award-winning beauty solutions that resonate with consumers in real life.”
This vision is expressed through a portfolio of innovations spanning next-gen exosomes and HMO biotech for skin regeneration, climate-adaptive care, a new era of sun protection and elevated hair care biotech, translating scientific ingenuity into real-world elevated beauty solutions.
EXOVIVE™ LIFT introduces a next-generation, eco-conscious plant-derived exosome innovation that speaks the skin’s native language to nurture, reprogram, and restore. ALPAFLOR® NEUROSOOTH advances heat-adaptive skincare through neurocosmetics that help interrupt the skin–mind stress loop while supporting emotional well being. GLYCARE® SK pioneering science, recently recognized with a scientific award in China, demonstrates the remarkable potential of HMOs biotechnology to activate skin’s natural regeneration, strengthen the barrier, and calm inflammation.
SUNNY SKIN MICROBIOME 2.0 reflects evolving sun care habits with a daily SPF approach that supports microbiome balance and helps keep C. acnes in check for a clearer-looking complexion. In hair care, BOND AID with OXY 229 CB is the biotech innovation that brings hair integrity and scalp vitality to brand-new levels.
“Our role is to deliver on our elevated science promise by translating cutting-edge research into tangible beauty solutions,” said Hendrik Reuter, VP Global R&D & Innovation, Beauty & Care at dsm-firmenich. “From pioneering work in exosomes to award-winning technologies such as GLYCARE®, our innovations are designed to turn advanced science into visible, measurable results.”
Sustainability is at the very heart of the Beauty & Care business purpose. Guided by ambitious targets and supported by positive impact measurement tools, dsm-firmenich enables the development of high-performing solutions aligned with the expectations of today’s conscious consumers, with positive impact for people and planet for generations to come.
Visitors to in-cosmetics Global are invited to discover these innovations at stand #3N40 in Paris, and experience how dsm-firmenich brings Dreamled Science to life through real-world, elevated beauty solutions.
Dreamled Science. Beautiful Reality Innovations & Capabilities.
Discover more
About dsm-firmenich
As innovators in nutrition, health, and beauty, dsm-firmenich reinvents, manufactures, and combines vital nutrients, flavors, and fragrances for the world’s growing population to thrive. With our comprehensive range of solutions, with natural and renewable ingredients and renowned science and technology capabilities, we work to create what is essential for life, desirable for consumers, and more sustainable for the planet. dsm-firmenich is a Swiss company with dual headquarters in Kaiseraugst, Switzerland and Maastricht, Netherlands, listed on the Euronext Amsterdam, with operations in almost 60 countries and revenues of more than €12 billion. With a diverse, worldwide team of nearly 30,000 employees, we bring progress to life every day, everywhere, for billions of people.
For more information
Global Marketing Communications Beauty & Care
beautycare.communications@dsm-firmenich.com
www.dsm-firmenich.com
Beauty & Care
LinkedIn | X | Instagram | Facebook
Forward-looking statements
This press release may contain forward-looking statements with respect to dsm-firmenich’s future performance and position. Such statements are based on current expectations, estimates and projections of dsm-firmenich and information currently available to the company. dsm-firmenich cautions readers that such statements involve certain risks and uncertainties that are difficult to predict and therefore it should be understood that many factors can cause actual performance, transaction progress and positions to differ materially from these statements. dsm-firmenich has no obligation to update the statements contained in this press release, unless required by law. This communication contains information that qualifies as inside information within the meaning of Article 7(1) of the EU Market Abuse Regulation. The English language version of this press release prevails over other language versions.